Knock-in mice models of FDD and FBD (FDDKI and FBDKI mice) showed that the mutant BRI2 proteins are mainly targeted for degradation, leading to a loss of mBRI2 function and, consequently, increased APP processing. The gene discussed is APP; the disease is ABri amyloidosis.